Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Questions
  3. EMQ
  4. Q55
EMQ

EMQ — Extended Matching Question · Review

Question 55

Feto-maternal medicine → Maturity

NextGen Workflow Status Needs Review
SQL status generated
Destination Site
Type EEMQ
UUID 7c94bbac-20a2-4f9c-afdf-1880b397e1e9

Classification

Speciality
Obstetrics and Gynaecology
Group
Clinical
Title
Feto-maternal medicine
Topic
Maturity
Subtopic 1
Related issue
Subtopic 2
Steroid
Subtopic 3
PPROM
Question Type
EMQ

Question

EEMQ
Question Header
Which of the following is the most appropriate approach to antenatal corticosteroid administration?
Question Stem
A woman at 31+0 weeks’ gestation presents with confirmed preterm prelabour rupture of membranes. There is no clinical evidence of infection and she is considered at increased risk of preterm birth.

Answer Bank

A Withhold corticosteroids because ruptured membranes abolish their neonatal benefit
B Give corticosteroids only after fetal lung maturity testing
C Offer antenatal corticosteroids because she is at increased risk of preterm birth following PPROM
D Give corticosteroids only if caesarean birth is planned
E Delay all obstetric management until a complete corticosteroid course has been administered
F Give routine weekly corticosteroid courses while the membranes remain ruptured
G Withhold corticosteroids because they invariably increase maternal infection
H Restrict corticosteroid treatment to pregnancies below 28 weeks

Correct Answer

C) Offer antenatal corticosteroids because she is at increased risk of preterm birth following PPROM

Explanation

Preterm prelabour rupture of membranes is an established clinical situation in which antenatal corticosteroids should be offered when the woman is at increased risk of preterm birth within the recommended gestational range. At 31+0 weeks, this woman is within the period in which neonatal benefits from corticosteroid treatment are well established. Rupture of the membranes does not remove the expected reduction in complications of prematurity, and fetal lung maturity testing is not required before treatment. A single course of antenatal corticosteroids does not invariably increase maternal infection. Management must nevertheless remain responsive to the overall clinical picture, particularly if infection or another indication for expedited birth develops. Evidence concerning repeat courses specifically after PPROM is more limited, so routine repeated weekly treatment is inappropriate. The correct approach is therefore a targeted course of antenatal corticosteroids because PPROM has placed this woman at significant risk of preterm birth.

Option Validity

A) PPROM does not abolish the neonatal benefit of antenatal corticosteroid exposure.

B) Fetal lung maturity testing is not required before treatment.

D) Corticosteroids are not restricted to women having planned caesarean birth.

E) Obstetric management should not be inappropriately delayed solely to complete corticosteroids.

F) Routine weekly repeat corticosteroid courses are not recommended.

G) A single course has not been shown to invariably increase maternal infection.

H) Recommended treatment extends well beyond 28 weeks of gestation.

Further Reading

Stock SJ, Thomson AJ, Papworth S, on behalf of the Royal College of Obstetricians and Gynaecologists. Antenatal corticosteroids to reduce neonatal morbidity and mortality. BJOG. 2022;129:e35–e60. RCOG Green-top Guideline No. 74. doi:10.1111/1471-0528.17027.

Source & metrics

Authored Difficulty
4.00
Evaluation Score
—
Destination
Site
Source
Antenatal corticosteroids to reduce neonatal morbidity and mortality
Source Section
Preterm prelabour rupture of membranes
Source Locator
—
Updated
2026-10-06 01:57:35
Difficulty Factor
Not available yet
Attended Users
No candidate-attempt data yet
Review Question